drugset
drugset / Trial / NCT03539718

Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.

NCT03539718 ↗

Phase 4 Unknown 60 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindPrevention

Summary

To assess the efficacy of Taurolock-hep500™ as anticoagulant and antimicrobial catheter lock solution in comparison to unfractionated heparin as alock solution to improve performance of hemodialysis catheters and quality of hemodialysis .

Timeline

Start
2018-05-15
Primary completion
2018-11
Completion
2019-02

Publications

  • Background FOGARTY, DAMIAN, and PETER MAXWELL.

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 5000 unknown Other
Subject taurolidine Small molecule — Other

Indications

thrombotic disease